Overview

Micro RNAs to Predict Response to Androgen Deprivation Therapy

Status:
Active, not recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Identify exosomal micro RNA that predict responses to ADT
Details
Lead Sponsor:
Medical College of Wisconsin
Treatments:
Androgens
Ascorbic Acid
Bicalutamide
Docetaxel
Estrogens, Conjugated (USP)
Goserelin
Leuprolide
Methyltestosterone
Triptorelin Pamoate